Crispr Therapeutics shares owned by Vident Investment Advisory
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vident Investment Advisory
from 13F filings
Historical chart of Vident Investment Advisory investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Vident Investment Advisory consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Vident Investment Advisory
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-06-30 | $491k | 8.7k | 56.14 |
2023-03-31 | $1.1M | 24k | 45.23 |
2022-12-31 | $869k | 21k | 40.65 |
2022-09-30 | $763k | 15k | 50.23 |
2022-06-30 | $769k | 13k | 60.58 |
2022-03-31 | $1.1M | 17k | 62.77 |
2021-12-31 | $1.1M | 15k | 75.81 |
2021-09-30 | $1.4M | 13k | 111.95 |
2021-06-30 | $2.3M | 14k | 161.89 |
2021-03-31 | $1.4M | 12k | 121.86 |
2020-12-31 | $1.8M | 12k | 153.08 |
2020-09-30 | $1.8M | 22k | 83.65 |
2020-06-30 | $1.7M | 23k | 73.48 |
2020-03-31 | $981k | 23k | 42.68 |
2019-12-31 | $1.4M | 24k | 60.92 |
2019-09-30 | $1.3M | 32k | 40.98 |
2019-06-30 | $1.5M | 33k | 47.09 |
More positions owned by Vident Investment Advisory
View all positions for Vident Investment Advisory